Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele

Science

Volumn 322, Issue 5900, 2008, Pages 449-452

  Stice, E ^a,b   Spoor, S ^a   Bohon, C ^a,c   Small, D M ^d,e  

^a OREGON RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF OREGON   (United States)

^d JOHN B PIERCE LABORATORY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR;

ALLEE EFFECT; ALLELE; FOOD INTAKE; HORMONE; OBESITY; POLYMORPHISM; SIGNALING;

ARTICLE; CORPUS STRIATUM; DRD2 GENE; FOOD INTAKE; GENE; HUMAN; OBESITY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REWARD; RISK FACTOR; SIGNAL TRANSDUCTION; TAQ1A GENE;

ADOLESCENT; ADULT; ALLELES; BASAL GANGLIA; BODY MASS INDEX; CAUDATE NUCLEUS; CORPUS STRIATUM; CUES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DOPAMINE; EATING; FEMALE; FOOD; HUMANS; HYPERPHAGIA; MAGNETIC RESONANCE IMAGING; OBESITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PUTAMEN; RECEPTORS, DOPAMINE D2; REGRESSION ANALYSIS; REWARD; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 54249101806     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1161550     Document Type: Article

References (34)

1. D. E. Comings, K. Blum, Prog. Brain Res. 126, 325 (2000).
2. D. M. Small, M. Jones-Gotman, A. Dagher, Neuroimage 19, 1709 (2003).
3. M. S. Szczypka et al., Neuron 30, 819 (2001).
4. D. M. Small, R. J. Zatorre, A. Dagher, A. C. Evans, M. Jones-Gotman, Brain 124, 1720 (2001).
5. G. Pagnoni, C. F. Zink, P. R. Montague, G. S. Berns, Nat. Neurosci. 5, 97 (2002).
6. D. M. Small, M. G. Veldhuizen, J. Felsted, Y. E. Mak, F. McGlone, Neuron 57, 786 (2008).
7. J. A. Gottfried, J. O'Doherty, R. J. Dolan, Science 301, 1104 (2003).
8. J. de Leon et al., J. Clin. Psychopharmacol. 27, 22 (2007).
9. J. J. Leddy et al., Obes. Res. 12, 224 (2004).
10. G. J. Wang et al., Lancet 357, 354 (2001).
11. N. D. Volkow et al., Neuroimage 42, 1537 (2008).
12. S. O. Fetissov, M. M. Meguid, T. Sato, L. H. Zhang, Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R905 (2002).
13. M. Orosco, C. Rouch, S. Nicolaidis, Appetite 26, 1 (1996).
14. G. J. Wang, N. D. Volkow, J. S. Fowler, Expert Opin. Ther. Targets 6, 601 (2002).
15. K. D'Ardenne, S. M. McClure, L. E. Nystrom, J. D. Cohen, Science 319, 1264 (2008).
16. W. Schultz, P. Dayan, P. R. Montague, Science 275, 1593 (1997).
17. B. Knutson, S. E. B. Gibbs, Psychopharmacology (Berlin) 191, 813 (2007).
18. K. Blum et al., Pharmacogenetics 6, 297 (1996).
19. M. R. Spitz et al., Nutr. Res. 20, 371 (2000).
20. P. A. Tataranni et al., Diabetes 50, 901 (2001).
21. E. P. Noble et al., Arch. Gen. Psychiatry 48, 648 (1991).
22. J. Thompson et al., Pharmacogenetics 7, 479 (1997).
23. T. Pohjalainen et al., Mol. Psychiatry 3, 256 (1998).
24. E. G. Jonsson et al., Mol. Psychiatry 4, 290 (1999).
25. T. Ritchie, E. P. Noble, Neurochem. Res. 28, 73 (2003).
26. E. Tupala et al., Neuroimage 19, 145 (2003).
27. M. Laruelle, J. Gelernter, R. Innis, Mol. Psychiatry 3, 261 (1998).
28. E. P. Noble, Am. J. Med. Genet. 116B, 103 (2003).
29. Materials and methods are available as supporting material on Science Online.
30. L. H. Epstein et al., Behav. Neurosci. 121, 877 (2007).
31. N. D. Volkow, J. S. Fowler, G. J. Wang, Behav. Pharmacol. 13, 355 (2002).
32. N. T. Bello, L. R. Lucas, A. Hajnal, Neuroreport 13, 1575 (2002).
33. C. Colantuoni et al., Neuroreport 12, 3549 (2001).
34. A. E. Kelley et al., Eur. J. Neurosci. 18, 2592 (2003).